{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:25:36Z","timestamp":1782451536679,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:00:00Z","timestamp":1774656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM122733-01A1"],"award-info":[{"award-number":["P30GM122733-01A1"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"U.S. Department of Health & Human Services | NIH | National Center for Research Resources","doi-asserted-by":"publisher","award":["C06RR14503"],"award-info":[{"award-number":["C06RR14503"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Chem"],"DOI":"10.1038\/s42004-026-01990-z","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T14:55:41Z","timestamp":1774709741000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cannabidiphorol (CBDP) acts as a negative allosteric modulator at two distinct sites of cannabinoid receptor 1"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9128-8254","authenticated-orcid":false,"given":"Pankaj","family":"Pandey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayat Hesham","family":"Zagzoog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodor","family":"Zaharia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamba","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikhlas A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason J.","family":"Paris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9994-433X","authenticated-orcid":false,"given":"Robert B.","family":"Laprairie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7047-5373","authenticated-orcid":false,"given":"Amar G.","family":"Chittiboyina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,28]]},"reference":[{"key":"1990_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-57369-0_1","volume":"1264","author":"EM Rock","year":"2021","unstructured":"Rock, E. M. & Parker, L. A. Constituents of Cannabis sativa. Adv. Exp. Med Biol. 1264, 1\u201313 (2021).","journal-title":"Adv. Exp. Med Biol."},{"key":"1990_CR2","doi-asserted-by":"publisher","first-page":"100798","DOI":"10.1016\/j.hermed.2023.100798","volume":"42","author":"SP Yadav","year":"2023","unstructured":"Yadav, S. P. et al. An overview of phytochemical constituents and pharmacological implications of Cannabis sativa L. J. Herb. Med. 42, 100798 (2023).","journal-title":"J. Herb. Med."},{"key":"1990_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.mehy.2005.08.026","volume":"66","author":"E Russo","year":"2006","unstructured":"Russo, E. & Guy, G. W. A tale of two cannabinoids: The therapeutic rationale for combining tetrahydrocannabinol and CBD. Med. Hypotheses 66, 234\u2013246 (2006).","journal-title":"Med. Hypotheses"},{"key":"1990_CR4","doi-asserted-by":"publisher","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","volume":"96","author":"A Zimmer","year":"1999","unstructured":"Zimmer, A., Zimmer, A. M., Hohmann, A. G., Herkenham, M. & Bonner, T. I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. USA 96, 5780\u20135785 (1999).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"1990_CR5","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1038\/npp.2009.31","volume":"34","author":"LE Wise","year":"2009","unstructured":"Wise, L. E., Thorpe, A. J. & Lichtman, A. H. Hippocampal CB1 receptors mediate the memory impairing effects of \u03949-tetrahydrocannabinol. Neuropsychopharmacol 34, 2072\u20132080 (2009).","journal-title":"Neuropsychopharmacol"},{"key":"1990_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00213-002-1169-0","volume":"164","author":"VH Curran","year":"2002","unstructured":"Curran, V. H., Brignell, C., Fletcher, S., Middleton, P. & Henry, J. Cognitive and subjective dose-response effects of acute oral \u03949-tetrahydrocannabinol in infrequent cannabis users. Psychopharmacology 164, 61\u201370 (2002).","journal-title":"Psychopharmacology"},{"key":"1990_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-56785-1","volume":"9","author":"C Citti","year":"2019","unstructured":"Citti, C. et al. A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than \u03949-tetrahydrocannabinol: \u03949-tetrahydrocannabiphorol. Sci. Rep. 9, 20335 (2019).","journal-title":"Sci. Rep."},{"key":"1990_CR8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.tips.2016.12.004","volume":"38","author":"EB Russo","year":"2017","unstructured":"Russo, E. B. Cannabidiol claims and misconceptions. Trends Pharmacol. Sci. 38, 198\u2013201 (2017).","journal-title":"Trends Pharmacol. Sci."},{"key":"1990_CR9","doi-asserted-by":"crossref","unstructured":"Salbini, M. et al. Oxidative stress and multi-organel damage induced by two novel phytocannabinoids, CBDB and CBDP, in breast cancer cells. Molecules 26, 5576 (2021).","DOI":"10.3390\/molecules26185576"},{"key":"1990_CR10","doi-asserted-by":"crossref","unstructured":"Bih, C. I. et al. Molecular targets ofcannabidiol in neurological disorders. Neurotherapeutics 12, 699\u2013730 (2015).","DOI":"10.1007\/s13311-015-0377-3"},{"key":"1990_CR11","doi-asserted-by":"publisher","first-page":"7724","DOI":"10.3390\/ijms25147724","volume":"25","author":"M Haghdoost","year":"2024","unstructured":"Haghdoost, M. et al. CBD versus CBDP: Comparing in vitro receptor-binding activities. Int. J. Mol. Sci. 25, 7724 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1990_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/sj.bjp.0707442","volume":"153","author":"R Pertwee","year":"2008","unstructured":"Pertwee, R. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: \u03949-tetrahydrocannabinol, cannabidiol and \u03949-tetrahydrocannabivarin. Br. J. Pharmacol. 153, 199\u2013215 (2008).","journal-title":"Br. J. Pharmacol."},{"key":"1990_CR13","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1111\/bph.14440","volume":"176","author":"M Tham","year":"2019","unstructured":"Tham, M. et al. Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors. Br. J. Pharmacol. 176, 1455\u20131469 (2019).","journal-title":"Br. J. Pharmacol."},{"key":"1990_CR14","doi-asserted-by":"publisher","first-page":"105508","DOI":"10.1016\/j.phrs.2021.105508","volume":"166","author":"LJ Martin","year":"2021","unstructured":"Martin, L. J., Banister, S. D. & Bowen, M. T. Understanding the complex pharmacology of cannabidiol: mounting evidence suggests a common binding site with cholesterol. Pharmacol. Res. 166, 105508 (2021).","journal-title":"Pharmacol. Res."},{"key":"1990_CR15","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1021\/acschemneuro.4c00343","volume":"16","author":"P Pandey","year":"2025","unstructured":"Pandey, P. et al. Determination of the negative allosteric binding site of cannabidiol at the CB1 receptor: a combined computational and site-directed mutagenesis study. ACS Chem. Neurosci. 16, 311\u2013328 (2025).","journal-title":"ACS Chem. Neurosci."},{"key":"1990_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.tips.2024.12.005","volume":"46","author":"OJ Manzoni","year":"2025","unstructured":"Manzoni, O. J., Manduca, A. & Trezza, V. Therapeutic potential of cannabidiol polypharmacology in neuropsychiatric disorders. Trends Pharmacol. Sci. 46, 145\u2013162 (2025).","journal-title":"Trends Pharmacol. Sci."},{"key":"1990_CR17","doi-asserted-by":"publisher","first-page":"100017","DOI":"10.1016\/j.molpha.2025.100017","volume":"107","author":"RW Tsien","year":"2025","unstructured":"Tsien, R. W. & Rosenberg, E. C. Ion channels and G protein-coupled receptors: cannabidiol actions on disorders of excitability and synaptic excitatory-inhibitory ratio. Mol. Pharmacol. 107, 100017 (2025).","journal-title":"Mol. Pharmacol."},{"key":"1990_CR18","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1111\/bph.13250","volume":"172","author":"RB Laprairie","year":"2015","unstructured":"Laprairie, R. B., Bagher, A. M., Kelly, M. E. & Denovan-Wright, E. M. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br. J. Pharmacol. 172, 4790\u20134805 (2015).","journal-title":"Br. J. Pharmacol."},{"key":"1990_CR19","unstructured":"Chittiboyina, A. G., Chatterjee, S., Pandey, P. & Khan, I. A. Cannabidiol-like compounds and methods for the selective preparation of the same. World Intellectual Property Organization, WO 2025006693 A1 (2025)."},{"key":"1990_CR20","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.3651","volume":"10","author":"JF Oliveira da Cruz","year":"2020","unstructured":"Oliveira da Cruz, J. F. et al. An alternative maze to assess novel object recognition in mice. Bio-Protoc. 10, e3651 (2020).","journal-title":"Bio-Protoc."},{"key":"1990_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41589-019-0387-2","volume":"15","author":"Z Shao","year":"2019","unstructured":"Shao, Z. et al. Structure of an allosteric modulator bound to the CB1 cannabinoid receptor. Nat. Chem. Biol. 15, 1199\u20131205 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1990_CR22","unstructured":"Schr\u00f6dinger Release 2024-3: Protein Preparation Wizard. (Schr\u00f6dinger, LLC, New York, NY, 2024)."},{"key":"1990_CR23","doi-asserted-by":"crossref","unstructured":"Ballesteros, J. A. & Weinstein, H. Integrated methods for the construction of three-dimensional models and computational probing of structure\u2013function relations in G protein-coupled receptors. In Methods Neurosci. 366\u2013428 (Academic Press, 1995).","DOI":"10.1016\/S1043-9471(05)80049-7"},{"key":"1990_CR24","unstructured":"Schr\u00f6dinger Release 2024-3: SiteMap. (Schr\u00f6dinger, LLC, New York, NY, 2024)."},{"key":"1990_CR25","unstructured":"Schr\u00f6dinger Release 2024-3: LigPrep. (Schr\u00f6dinger, LLC, NeROw York, NY, 2024)."},{"key":"1990_CR26","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.1021\/acs.jctc.1c00302","volume":"17","author":"C Lu","year":"2021","unstructured":"Lu, C. et al. OPLS4: improving force field accuracy on challenging regimes of chemical space. J. Chem. Theory Comput. 17, 4291\u20134300 (2021).","journal-title":"J. Chem. Theory Comput."},{"key":"1990_CR27","doi-asserted-by":"publisher","first-page":"6177","DOI":"10.1021\/jm051256o","volume":"49","author":"RA Friesner","year":"2006","unstructured":"Friesner, R. A. et al. Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein\u2013ligand complexes. J. Med. Chem. 49, 6177\u20136196 (2006).","journal-title":"J. Med. Chem."},{"key":"1990_CR28","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1002\/prot.10613","volume":"55","author":"MP Jacobson","year":"2004","unstructured":"Jacobson, M. P. et al. A hierarchical approach to all-atom protein loop prediction. Proteins 55, 351\u2013367 (2004).","journal-title":"Proteins"},{"key":"1990_CR29","doi-asserted-by":"publisher","first-page":"026988112513607","DOI":"10.1177\/02698811251360745","volume":"39","author":"E MacNicol","year":"2025","unstructured":"MacNicol, E. et al. Acute cannabidiol (CBD), tetrahydrocannabinol (THC) and their mixture (THC:CBD) exert differential effects on brain activity and blood flow in rats: a translational neuroimaging study. J. Psychopharmacol. 39, 02698811251360745 (2025).","journal-title":"J. Psychopharmacol."},{"key":"1990_CR30","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1016\/j.euroneuro.2017.10.037","volume":"27","author":"T Hlo\u017eek","year":"2017","unstructured":"Hlo\u017eek, T. et al. Pharmacokinetic and behavioural profile of THC, CBD, and THC + CBD combination after pulmonary, oral and subcutaneous administration in rats and confirmation of in vivo conversion of CBD to THC. Eur. Neuropsychopharmacol. 27, 1223\u20131237 (2017).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"1990_CR31","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1111\/bph.12199","volume":"170","author":"MJ Wright Jr","year":"2013","unstructured":"Wright, M. J. Jr, Vandewater, S. A. & Taffe, M. A. Cannabidiol attenuates deficits of visuospatial associative memory induced by \u0394\u2079-tetrahydrocannabinol. Br. J. Pharmacol. 170, 1365\u20131373 (2013).","journal-title":"Br. J. Pharmacol."}],"container-title":["Communications Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-01990-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-01990-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-01990-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T22:50:15Z","timestamp":1779403815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42004-026-01990-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,28]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1990"],"URL":"https:\/\/doi.org\/10.1038\/s42004-026-01990-z","relation":{},"ISSN":["2399-3669"],"issn-type":[{"value":"2399-3669","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,28]]},"assertion":[{"value":"20 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing financial interest(s): R.B.L. has received compensation on legal cases involving Cannabis, has served as a consultant on the scientific advisory board for Shackleford Pharma Inc., and is pursuing patents on compounds unrelated to the contents of this study. P.P., A.Z., R.B.L., R.J.D., I.A.K. and A.G.C have filed a patent application for compounds related to, and including CBDP described in this manuscript. This disclosure is provided for transparency regarding their ongoing work. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"186"}}